Research map: Factors Associated with Increased Healthcare Utilization Within 30 and 90 Days Post-Discharge of CAR-T Cell Therapy in Patients with R/R LBCL

Back to the article

Papers in this map

  1. Regression Modeling Strategies · Frank E. Harrell · 2015 · 6833 citations · Cited by this paper
  2. Concomitant Clonal CBFB::MYH11 and PDGFRB Fusions in a Case of De Novo Acute Myeloid Leukemia · 2026 · Related
  3. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma · Sattva Swarup Neelapu · 2017 · 6103 citations · Cited by this paper
  4. Complexities in the Diagnostic Evaluation and Treatment of Infant Hemophagocytic Lymphohistiocytosis · 2026 · Related
  5. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma · Stephen J. Schuster · 2018 · 4159 citations · Cited by this paper
  6. The Utility of IgG4/IgG Ratio in the Diagnosis of Multicentric Castleman Disease: A Case Report of HHV8+ Castleman Disease in a Patient with Classical Hodgkin’s Lymphoma · 2026 · Related
  7. Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial · Manali Kamdar · 2022 · 802 citations · Cited by this paper
  8. Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma · 2026 · Related
  9. Statistics review 6: Nonparametric methods. · Elise Whitley · 2002 · 338 citations · Cited by this paper
  10. Advances in Gene Therapy for Inherited Haemoglobinopathies · 2025 · Related
  11. A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy · David M. Cordas dos Santos · 2024 · 287 citations · Cited by this paper
  12. Inherited Platelet Disorders During Pregnancy and Delivery: Overview of Management Strategies and Emerging Therapeutic Considerations · 2026 · Related
  13. High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions · Edward R. Scheffer Cliff · 2023 · 132 citations · Cited by this paper
  14. Primary Bone Lymphoma of the Jaw Masquerading as Infection and Delaying Treatment · 2026 · Related
  15. Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma · Dai Chihara · 2023 · 102 citations · Cited by this paper
  16. Clinical Experience with Emicizumab and Rituximab as First-Line Treatment in a Case Series of Acquired Hemophilia A · 2026 · Related
  17. CAR‑T cell therapy: A breakthrough in traditional cancer treatment strategies (Review) · Dahua Sun · 2024 · 91 citations · Cited by this paper
  18. Quality of Life in CAR-T Cell Therapy · 2026 · Related
  19. CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis · Jinchul Kim · 2024 · 62 citations · Cited by this paper
  20. Asciminib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Case Series and Review of Emerging Evidence · 2026 · Related
  21. Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis? · Brandon Douglas Brown · 2021 · 56 citations · Cited by this paper
  22. Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy · Ajlan Al Zaki · 2022 · 46 citations · Cited by this paper
  23. Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells · Zhenyu Wei · 2023 · 38 citations · Cited by this paper
  24. Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States · Josephine Emole · 2022 · 34 citations · Cited by this paper
  25. Healthcare Utilization and End-of-Life Outcomes in Patients Receiving CAR T-Cell Therapy · Patrick Connor Johnson · 2021 · 27 citations · Cited by this paper
  26. Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort · Corentin Le Cacheux · 2024 · 24 citations · Cited by this paper
  27. Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas · Mengyang Di · 2024 · 24 citations · Cited by this paper
  28. Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy · Patrick Connor Johnson · 2024 · 23 citations · Cited by this paper
  29. Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience · Aaron Trando · 2023 · 20 citations · Cited by this paper
  30. Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma · James J. Wu · 2024 · 18 citations · Cited by this paper
  31. Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy · Aditi Mulgaonkar · 2023 · 17 citations · Cited by this paper
  32. Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States · Richard Thomas Maziarz · 2022 · 15 citations · Cited by this paper
  33. Epidemiology and Predictors of 30-Day Readmission in CAR-T Cell Therapy Recipients · Aditi Sharma · 2022 · 15 citations · Cited by this paper
  34. Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by 18F-FDG PET/CT Imaging Following CAR-T Therapy · Forat Umair Lutfi · 2023 · 13 citations · Cited by this paper
  35. Assessment of Hospitalizations and Emergency Department Visits After Chimeric Antigen Receptor T-Cell Therapy Among Commercially Insured Patients · Kelly Marie Kenzik · 2022 · 10 citations · Cited by this paper
  36. Sex Differences in Outcomes of Chimeric Antigen Receptor ( CAR ) T‐Cell Therapy · Jia Yi Tan · 2025 · 8 citations · Cited by this paper
  37. Statistics for Health Data Science · Ruth Etzioni · 2020 · 4 citations · Cited by this paper
  38. Systematic review and meta−analysis of PET−based prognostic metrics in CAR−T treatment of DLBCL · Chirong Long · 2026 · 2 citations · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)